Reach Us +1 947-333-4405


<em>Fallopia japonica</em>: Bioactive Secondary Metabolites and Molecular Mode of Anticancer | OMICS International | Abstract
ISSN: 2573-4555

Journal of Traditional Medicine & Clinical Naturopathy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Fallopia japonica: Bioactive Secondary Metabolites and Molecular Mode of Anticancer

Mahmoud Zaki El-Readi1,2*, Safaa Yehia Eid1,3, Hiba Saeed Al-Amodi1 and Michael Wink3*

1Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, K.S.A

2Department of Biochemistry, Faculty of Pharmacy, Al-Azhar University, 71524 Assiut, Egypt

3Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany

Corresponding Author:
Dr. Mahmoud Zaki El-Readi
Department of Clinical Biochemistry
Faculty of medicine, Umm Al-Qura University
Abdia, Makkah, Saudia Arabia
Tel: +966-25270000/ 4347
Fax: +96625270000/4319
E-mail: [email protected]
Dr. Michael Wink
Institut für Pharmazie und Molekulare Biotechnologie
Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany
Tel: +49 6221 54 4880
Fax: +49 6221 54 4884
E-mail: [email protected]

Received Date: September 19, 2016; Accepted Date: October 12, 2016; Published Date: October 17, 2016

Citation: El-Readi MZ, Eid SY, Al-Amodi HS, Wink M (2016) Fallopia japonica: Bioactive Secondary Metabolites and Molecular Mode of Anticancer. J Tradi Med Clin Natur 5:193.

Copyright: © 2016 El-Readi MJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Traditional medicinal plants are a large source of natural anticancer compounds that might serve as leads for the development of novel drugs. In recent years, the scientific community in the Western world has recognized the potential of natural products, used in Traditional Chinese Medicine (TCM). Since ancient times Japanese knotweed (Fallopia japonica), has been utilized in many TCM herbal preparations as anti-cancer agent. F. japonica (FJ) is known to produce a series of bioactive secondary metabolites, including anthraquinones, stilbens, tannins, lignans, anthocyanins, phenethyl alcohols, sterols, and essential oils. Resveratrol (a stilben) and emodin (an anthraquinone) are the major active ingredients of FJ. The anticancer activity of both compounds has various molecular modes of action and mechanisms through their ability to modulate the proliferation, apoptosis, cell cycle, growth factors, protein kinase C (PKC), NF-kappa B (NF-κB), and mitogen-activated protein kinase (MAPK) signaling cascades. This review presents an overview of the secondary metabolites of F. japonica and anticancer activities of the extract and main active principles, resveratrol and emodin. The possible molecular targets and potential chemopreventive effects are discussed.